您的位置: 首页 > 农业专利 > 详情页

ANTICANCER FUSION PROTEIN
专利权人:
ADAMED SP. Z O.O.
发明人:
PIECZYKOLAN, JERZY SZCZEPAN,PAWLAK, SEBASTIAN DOMINIK,ZEREK, BARTLOMIEJ MACIEJ,ROZGA, PIOTR KAMIL
申请号:
PH12014501363
公开号:
PH12014501363A1
申请日:
2014.06.16
申请国别(地区):
PH
年份:
2014
代理人:
摘要:
A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70 pcnt sequence identity, preferably 85 pcnt identity and ending with the amino acid hTRAIL281 and at least one domain (b) which is a sequence of a cytolytic effector peptide forming pores in the cell membrane, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a).The fusion protein can be used for the treatment of cancer diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充